References
- Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Exp Rev Anti-Infect Ther 2013; 11:297-308; PMID:23458769; http://dx.doi.org/10.1586/eri.13.12
- Willemsen I, Cooper B, van Buitenen C, Winters M, Andriesse G, Kluytmans J. Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother 2010; 54:3763-9; PMID:20585135; http://dx.doi.org/10.1128/AAC.01581-09
- Levy SB, O'Brien TF, Alliance for the Prudent Use of A. Global antimicrobial resistance alerts and implications. Clin Infect Dis 2005; 41 Suppl 4:S219-20; PMID:16032554; http://dx.doi.org/10.1086/432443
- Lang LH. FDA approves use of bacteriophages to be added to meat and poultry products. Gastroenterology 2006; 131:1370; PMID:17067600
- Abuladze T, Li M, Menetrez MY, Dean T, Senecal A, Sulakvelidze A. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl Environ Microbiol 2008; 74:6230-8; PMID:18723643; http://dx.doi.org/10.1128/AEM.01465-08
- Edgar R, Friedman N, Molshanski-Mor S, Qimron U. Reversing Bacterial Resistance to Antibiotics by Phage-Mediated Delivery of Dominant Sensitive Genes. Appl Environ Microbiol 2012 Feb; 78(3):744-51; PMID:22113912
- Lukits A. A New Weapon in the Fight Against Superbugs. Wall Street J 2012; Retrieved from http://www.wsj.com/articles/SB10001424052970204331304577144853241744454.
- Gravitz L. Turning a new phage. Nat Med 2012; 18:1318-20; PMID:22961150; http://dx.doi.org/10.1038/nm0912-1318
- Jermy A. Antimicrobials: Reversing resistance with phage. Nat Rev Microbiol 2011; 10:83; PMID:22203376
- Yosef I, Manor M, Kiro R, Qimron U. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A 2015; 112:7267-72; PMID:26060300; http://dx.doi.org/10.1073/pnas.1500107112
- Marraffini LA, Sontheimer EJ. CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 2010; 11:181-90; PMID:20125085; http://dx.doi.org/10.1038/nrg2749
- Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007; 315:1709-12; PMID:17379808; http://dx.doi.org/10.1126/science.1138140
- Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, Terns RM, Terns MP. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 2009; 139:945-56; PMID:19945378; http://dx.doi.org/10.1016/j.cell.2009.07.040
- Bikard D, Euler CW, Jiang W, Nussenzweig PM, Goldberg GW, Duportet X, Fischetti VA, Marraffini LA. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 2014; 32:1146-50; PMID:25282355; http://dx.doi.org/10.1038/nbt.3043
- Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 2014; 32(11):1141-5; PMID:25240928
- Marraffini LA, Sontheimer EJ. CRISPR inteference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008; 322:1843-5; PMID:19095942; http://dx.doi.org/10.1126/science.1165771